on Eckert & Ziegler Strahlen- Und Medizintechnik AG (isin : DE0005659700)
Eckert & Ziegler Increases 2024 Financial Forecast
Eckert & Ziegler SE has raised its financial forecast for 2024, reflecting positive business performance. The company now anticipates sales of approximately EUR 290 million, up from a previous estimate of EUR 265 million. Additionally, the EBIT before special items is projected to reach around EUR 60 million, an increase from the earlier forecast of EUR 55 million.
This adjustment follows the release of strong 9-month figures for 2024 and optimism about the final quarter's potential. Eckert & Ziegler's upward revision signals continued growth and a robust market position within the industry.
The company is listed on the SDAX and TecDAX, with shares traded on several German exchanges. For further information, interested parties can contact the Investor Relations department.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Eckert & Ziegler Strahlen- Und Medizintechnik AG news